Rights and permissions
About this article
Cite this article
Infliximab sits well within NICE threshold relative to palliative care. Pharmacoecon. Outcomes News 622, 5 (2011). https://doi.org/10.2165/00151234-201106220-00009
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-201106220-00009